‰HDF  ÿÿÿÿÿÿÿÿXìÿÿÿÿÿÿÿÿ`ˆ¨ ( TREEÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿHEAPX Èdatadata_descr8ˆ¨ (namecsb-ch14 (mldata0 ¨ comment‚ ____________________________________________________________________ Data Diskette for CASE STUDIES IN BIOMETRY By Nicholas Lange, Louise Ryan and Lynne Brillard, David Brillinger, Loveday Conquest, Joel Greenhouse. Published by John Wiley & Sons, Inc., copyright 1994. ____________________________________________________________________ You have obtained all of the data used by all of the authors in the twenty-one chapters of Case Studies in Biometry. Each chapter contains either one or two data sets, except for Chapter 19, which has seven data sets. Corresponding to each data set are ASCII files with extensions ".dat" (the data), ".txt" (the data description file), and ".sas" (a simple SAS program to read the .dat file). For chapters containing only one data set, the file name prefix is "ch" followed by chapter number, and then the above extensions. For instance, for Chapter 2 you will find files "ch2.dat", "ch2.txt", and "ch2.sas". For chapters containing two data sets, the letters "a" and "b" are added after the chapter number. For instance, for Chapter 1, you will find the files "ch1a.dat", "ch1a.txt", "ch1a.sas", "ch1b.dat", "ch1b.txt", "ch1b.sas". For chapter 19, there are seven data sets, ch19a.dat through ch19g.dat. Each one has the same format, but refers to different subsets of the whole data set. Details are given in the single text file, ch19.txt. Please note permissions and usage information included in the .txt file for each subset. _______________________________________________________________ %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% File: ch14.dat %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% File specific Information: %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% CASE STUDIES IN BIOMETRY: Chapter 14. Interpretation of a Leukemia Trial Stopped Early Scott S. Emerson, Phillip L. C.Banks The file ch14.dat contains the following 19 variables: Patient ID Date on study (MMDDYY) Treatment arm (D= daunorubicin, I= idarubicin) Sex (M= male, F= female) Age (years) FAB classification (1 - 6) Karnofsky score (0 - 100) Baseline white blood cells (in thousands per cubic millimeter) Baseline platelets (in thousands per cubic millimeter) Baseline hemoglobin (g/dl) Evaluable (Y= yes, N= no) Complete remission (CR) (Y= yes, N= no) Courses of chemotherapy to CR Date of CR (MMDDYY) Date of last follow-up (MMDDYY) Status at last follow-up (D= dead, A= alive) Bone marrow transplant (Y= yes, N= no) Date of bone marrow transplant (MMDDYY) Inclusion in June 30, 1988 analysis (Y= yes, N= no) Information about the dataset CLASSTYPE: numeric CLASSINDEX: none specific p�TREEÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ`pŒÐð”€HEAP`è`�øÞÈŽSNODH°‚¨ 'ÕL€SNODHè.h¸18Ø-PÈ‚È�È€È~ÈÈzÈ{È|È}ÈrÈsÈtÈuÈvÈwÈxÈyÈbÈcÈdÈeÈfÈgÈhÈiÈjÈkÈlÈmÈnÈoÈpÈqÈBÈCÈDÈEÈFÈGÈHÈIÈJÈKÈLÈMÈNÈOÈPÈQÈRÈSÈTÈUÈVÈWÈXÈYÈZÈ[È\È]È^È_È`ÈaÈÈÈÈÈÈÈÈÈ È È È È ÈÈÈÈÈÈÈÈÈÈÈÈÈÈÈÈÈÈÈ È!È"È#È$È%È&È'È(È)È*È+È,È-È.È/È0È1È2È3È4È5È6È7È8È9È:È;È<È=È>È?È@ÈAGCOLYYYYYYYY Y Y Y Y YYYYYYYYYYYYYNNNNNN N!N"N#N$N%N&N'N(N)N*N+N,N-N.N/N0N1N2N3N4N5N6N7N8N9N:N;N<N=N>N?N@NANBYCYDYEYFYGYHYIYJYKYLYMYNYOYPYQYRYSYTYUYVYWYXYYYZY[Y\Y]Y^Y_Y`YaYbYcYdYeYfYgYhYiYjYkYlYmYnYoYpYqYrYsYtYuYvYwYxYyYzY{Y|Y}Y~YY€Y�Y‚YƒY„Y…Y†Y‡YˆY‰YŠY‹YŒY�YŽY�Y�Y‘Y’Y“N”Y•Y–Y—Y˜Y™YšN›YœY�YžYŸY Y¡Y¢Y£Y¤Y¥N¦Y§Y¨Y©YªN ‚È4'ÕLˆ‚Ð6 'ÕL€‚ðN 'ÕL€‚g 'ÕL€‚0 'ÕL€ ‚P‡'ÕL€ÈÅ^ ÈÅ]ÈÅ[ÈÅ\ÈÅWÈÅXÈÅY ÈÅZÈÅPÈÅQÈÅRÈÅSÈÅTÈÅU"ÈÅV3G.&@7>xë$æ$:OV!šN (:$‘r/}•¬2€;…'$6F…0o>”JM++!9v^#@nog<É?* (Y9!.#[%h†9_(0M…R¤ c\Dd_1¸ w.S|&.‘<%%AH^"Ö:?ð>Zð>Yð>Xð>Vð>Wð>Rð>Sð>Tð>Uð>Jð>Kð>Lð>Mð>Nð>Oð>Pð>Qð>:ð>;ð><ð>=ð>>ð>?ð>@ð>Að>Bð>Cð>Dð>Eð>Fð>Gð>Hð>Ið>ð>ð>ð>ð>ð>ð> ð>!ð>"ð>#ð>$ð>%ð>&ð>'ð>(ð>)ð>*ð>+ð>,ð>-ð>.ð>/ð>0ð>1ð>2ð>3ð>4ð>5ð>6ð>7ð>8ð>9ȃȄȅȆȇȈȉȊȋȌÈ�ÈŽÈ�È�ȑȒȓȔȕȖȗȘșȚțȜÈ�ȞȟȠȡȢȣȤȥȦȧȨȩȪð>ð>ð>ð>ð>ð>ð>ð>ð> ð> ð> ð> ð> ð>ð>ð>ð>ð>ð>ð>ð>ð>ð>ð>ð>GCOLNYYYYYYY Y Y Y Y YYNYYNYYYYYYYYYYYYY Y!Y"Y#Y$Y%Y&Y'Y(Y)Y*Y+Y,Y-Y.Y/Y0Y1Y2Y3Y4Y5Y6N7Y8Y9Y:Y;Y<Y=Y>Y?Y@YAYBYCYDYEYFYGYHYIYJYKYLYMNNYOYPNQYRYSYTYUYVYWYXYYYZY[N\N]Y^N_N`NaNbNcNdNeNfNgNhNiNjNkNlNmNnNoNpNqNrNsNtNuNvNwNxNyNzN{Y|N}N~YN€N�N‚NƒN„Y…N†N‡NˆN‰NŠN‹NŒN�NŽN�Y�N‘N’N“N”N•N–N—N˜N™NšN›NœN�YžYŸN N¡N¢N£N¤N¥N¦N§N¨N©NªNW2W1W0W.W/W*W+W,W-W"W#W$W%W&W'W(W)WWWWWWWWWWWWWWW W!ð>œð>�ð>žð>Ÿð> ð>¡ð>¢ð>£ð>¤ð>¥ð>¦ð>§ð>¨ð>©ð>ªWWWWWWWWW W W W W WWWWð>[ð>\ð>]ð>^ð>_ð>`ð>að>bð>cð>dð>eð>fð>gð>hð>ið>jð>kð>lð>mð>nð>oð>pð>qð>rð>sð>tð>uð>vð>wð>xð>yð>zð>{ð>|ð>}ð>~ð>ð>€ð>�ð>‚ð>ƒð>„ð>…ð>†ð>‡ð>ˆð>‰ð>Šð>‹ð>Œð>�ð>Žð>�ð>�ð>‘ð>’ð>“ð>”ð>•ð>–ð>—ð>˜ð>™ð>šð>›GCOLNYNNNNYN N N N N NNYNYNNNNNNNNNYNYNN N!N"N#N$Y%N&N'N(N)N*N+N,N-N.N/N0N1N2N3F4F5M6F7F8M9M:M;F<F=F>M?M@MAFBMCMDFEMFMGMHFIFJMKMLFMMNMOMPFQFRFSMTMUMVMWMXFYMZF[M\F]F^F_F`MaFbFcFdFeMfFgMhMiFjFkMlMmFnMoFpFqFrFsMtFuFvMwFxMyMzF{F|M}M~MF€F�M‚MƒM„F…F†F‡MˆM‰FŠF‹MŒM�MŽM�F�F‘F’F“M”F•F–F—M˜M™MšM›FœM�FžFŸF M¡M¢F£F¤M¥F¦M§F¨F©FªM0o 0o 0o0o0o0o0o0o0oW¤W¥W¦W§W¨W©Wª0oW”W•W–W—W˜W™WšW›WœW�WžWŸW W¡W¢W£WtWuWvWwWxWyWzW{W|W}W~WW€W�W‚WƒW„W…W†W‡WˆW‰WŠW‹WŒW�WŽW�W�W‘W’W“W3W4W5W6W7W8W9W:W;W<W=W>W?W@WAWBWCWDWEWFWGWHWIWJWKWLWMWNWOWPWQWRWSWTWUWVWWWXWYWZW[W\W]W^W_W`WaWbWcWdWeWfWgWhWiWjWkWlWmWnWoWpWqWrWsGCOLFMFMMMFM M M Y Y YYYYNYYYNNYYYYNYNNN Y!N"Y#N$Y%N&N'Y(Y)Y*Y+Y,N-Y.Y/Y0Y1Y2Y3Y4Y5Y6Y7Y8N9Y:N;N<N=N>Y?Y@YAYBYCYDNEYFYGNHYIYJNKYLYMYNYOYPYQYRYSNTNUYVNWNXYYYZY[Y\Y]Y^Y_Y`NaYbNcNdYeYfNgYhNiYjYkYlYmYnYoNpYqYrYsYtNuYvYwYxNyYzN{N|Y}Y~YY€Y�N‚NƒY„Y…Y†N‡NˆY‰YŠN‹NŒN�DŽD�I�I‘I’I“D”D•I–I—D˜D™IšI›DœD�IžIŸD D¡I¢D£I¤D¥I¦I§I¨D©DªD0oŒ0o‹0oŠ0oˆ0o‰0o„0o…0o†0o‡0o|0o}0o~0o0o€0o�0o‚0oƒ0ol0om0on0oo0op0oq0or0os0ot0ou0ov0ow0ox0oy0oz0o{0oL0oM0oN0oO0oP0oQ0oR0oS0oT0oU0oV0oW0oX0oY0oZ0o[0o\0o]0o^0o_0o`0oa0ob0oc0od0oe0of0og0oh0oi0oj0ok0o 0o 0o 0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o0o 0o!0o"0o#0o$0o%0o&0o'0o(0o)0o*0o+0o,0o-0o.0o/0o00o10o20o30o40o50o60o70o80o90o:0o;0o<0o=0o>0o?0o@0oA0oB0oC0oD0oE0oF0oG0oH0oI0oJ0oK€€€Š±+à-(€€1Q™záU%ž]�€€¡Ùa…=)�€5�ÝÕY¹á³€þ/úQŠS€~ €€ËË"ò‚É>Ì:î.¥€€.;€€ªiîfjî±nŒzÕW}®Ý€kP€€W2SŸ€;X€¯ÊoöÏÍSg:ah;kÓŒ€h|,sµ€€CÖP$*ÜN€ÌY€€€ä €t¢€Í€€ˆòøð 9T€ô`¤˜dpA¸gTg$ˆ°ÝÈŽŽ€|Õ€€€€‘1°Ýí*áw­Ve{€qÄi¤€‰§%§€™A™B.(}³.¸5á)×¢}hÒŒ5áKciÍÂfï2d:¶5áµ²5ᾇÝa5áv.ð5á5áO¨ƒ3*|rµgïB‹¾¹5á5áGVó�¿)ƒàÕ‡=¾<Ãe{Š5áj5áCõÓ×+D4´v{Õëò5á¨@·T€h›�5áhY5áD‹5á?5á5ᢈ*5á)5á™ÎX�:Tgñž]¦Äe�Ú5álc9zY2ô|œ�ì=5á˜Î™%=‘�I¡5á5ápö9B5á,Ú5á5á¥bAÌ5á5á5á5ᘩ?˜©@˜©A˜©B˜©C0o�0oŽ0o�0o�0o‘0o’0o“0o”0o•0o–0o—0o˜0o™0oš0o›0oœ0o�0ož0oŸ0o 0o¡0o¢0o£0o¤0o¥0o¦0o§0o¨0o©0oª˜©˜©˜©˜©˜©˜©˜©˜©˜© ˜© ˜© ˜© ˜© ˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜©˜© ˜©!˜©"˜©#GCOLIIDDIDII D I D I DIIDDDIDIIDDIIDIDID I!I"D#D$D%I&I'I(I)D*D+I,D-D.D/I0D1I2I3I4D5I6D7I8I9D:D;D<I=D>D?I@DAIBDCIDDEIFIGDHIIIJDKILDMDNIOIPDQDRISDTIUDVIWDXIYDZD[I\I]D^D_I`IaDbIcDdDeDfAgDhAiAjDkDlAmDnAoDpDqDrDsDtDuDvDwAxDyDzD{D|D}D~AD€D�D‚DƒD„A…A†D‡DˆA‰DŠA‹AŒD�DŽA�A�A‘A’D“A”D•D–D—D˜D™AšA›AœA�AžAŸA A¡A¢A£A¤D¥A¦D§D¨D©AªA`f@ÍÌÌÌÌÌì?ÍÌÌÌÌÌü?fffffæ?@ffffff8@š™™™™G@š™™™™7@`b@ffffff&@€3@ð?ffffff@ÍÌÌÌÌÌ)@š™™™™™+@ÍÌÌÌÌÌ:@fffff¦O@333333@ÍÌÌÌÌÌ@š™™™™™é?33333³N@ÍÌÌÌÌÌ@š™™™™™@ffffffR@33333³1@33333³:@€Z@€L@ð?33333³0@ÍÌÌÌÌÌ*@ffffff@ffffff%@U@š™™™™™é?ffffffþ?"@ÍÌÌÌÌÌ*@ffffff=@333333ó?ÍÌÌÌÌÌì?ffffffN@ø333333!@€G@@T@ffffff6@fffffæE@š™™™™™Ù?333333B@333333@33333óG@š™™™™™+@333333@ð?ÍÌÌÌÌÌ@ÍÌÌÌÌL1@€^@333333ó? a@€_@333333@š™™™™™@ffffff,@33333³8@ffffffR@š™™™™™ @ffffff)@ffffff@ffffff@333333û?333333@@[@ÍÌÌÌÌŒV@ @@@@@`c@333333@33333óD@š™™™™™é?àj@33333Cc@@ffffffæ?š™™™™6@š™™™™™7@333333@ÍÌÌÌÌÌ@@š™™™™™ñ?À\@`a@ffffff@ÍÌÌÌÌÌô?333333@ Q@33333sL@€b@333333û?ÍÌÌÌÌ,U@333333 @ÍÌÌÌÌÌ@š™™™™™ñ?€2@š™™™™™@š™™™™0@fffff¦B@ffffff@@`@@333333O@@33333“Q@š™™™™ÙC@ T@ffffff4@š™™™™B@333333@À`@fffff¦C@`Q@š™™™™YQ@š™™™™™'@ a@@333333E@ð?333333@@ÍÌÌÌÌÌ @ÈÅ<ÈÅ;ÈÅ:ÈÅ8ÈÅ9ÈÅ4ÈÅ5ÈÅ6ÈÅ7ÈÅ,ÈÅ-ÈÅ.ÈÅ/ÈÅ0ÈÅ1ÈÅ2ÈÅ3ÈÅÈÅÈÅÈÅÈÅ ÈÅ!ÈÅ"ÈÅ#ÈÅ$ÈÅ%ÈÅ&ÈÅ'ÈÅ(ÈÅ)ÈÅ*ÈÅ+˜©¦˜©§˜©¨˜©©˜©ªÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅ ÈÅ ÈÅ ÈÅ ÈÅ ÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈÅÈŘ©e˜©f˜©g˜©h˜©i˜©j˜©k˜©l˜©m˜©n˜©o˜©p˜©q˜©r˜©s˜©t˜©u˜©v˜©w˜©x˜©y˜©z˜©{˜©|˜©}˜©~˜©˜©€˜©�˜©‚˜©ƒ˜©„˜©…˜©†˜©‡˜©ˆ˜©‰˜©Š˜©‹˜©Œ˜©�˜©Ž˜©�˜©�˜©‘˜©’˜©“˜©”˜©•˜©–˜©—˜©˜˜©™˜©š˜©›˜©œ˜©�˜©ž˜©Ÿ˜© ˜©¡˜©¢˜©£˜©¤˜©¥GCOLDDDDDDDD D A D A DDDDDDDADDDDADADDAD A!D"D#A$D%D&A'A(D)D*D+D,D-D.A/D0D1D2D3D4D5A6D7D8D9D:D;D<D= Evaluable>Complete_remission?Courses_of_chemotherapy_to_CR@ Date_of_CRADate_of_last_follow-upBStatus_at_last_follow-upCBone_marrow_transplantDDate_of_bone_marrow_transplantE"Inclusion_in_June_30_1988_analysisFFAB_classificationGKarnofsky_scoreHBaseline_white_blood_cellsIBaseline_plateletsJBaseline_hemoglobinKSexLAgeM Treatment_armN Date_on_studyO Patient_IDPComplete_remissionQdouble5Rint6SStatus_at_last_follow-upTBone_marrow_transplantUdouble7V"Inclusion_in_June_30_1988_analysisWdouble2Xint3Ydouble4Z Evaluable[Sex\int1] Treatment_arm^int0_ nominal:N,Y` nominal:N,Ya nominal:1,2bnumericcnumericd nominal:A,De nominal:N,Yfnumericg nominal:N,Yhnumericinumericjnumericknumericlnumericm nominal:F,Mnnumerico nominal:D,Ipnumericqnumeric°øøøøøøøøøøøö@øøøøøøøøøøøøøø€¬Ý@øÀ¿è@øøøøø zñ@`Øó@øøøøøøøøøøøøøÀèÓ@øøøø`4à@øøøøøøø°Wý@ø°ö@øøÔ@øøøøøøøøøøøøøøøøøøøøøøøøøøøøø€Ç@øø€–È@øøøøøÀ¢ý@øøøøøøøøøø ¨î@øøøøøøøøøøøøš™™™™™!@333333*@š™™™™™@š™™™™™%@ffffff$@#@š™™™™™"@333333!@333333#@333333#@ @ffffff$@(@"@š™™™™™"@333333%@š™™™™™"@š™™™™™"@ÍÌÌÌÌÌ!@333333@š™™™™™#@ffffff+@ÍÌÌÌÌÌ!@ffffff#@š™™™™™&@ÍÌÌÌÌÌ+@š™™™™™ @ffffff @ffffff@š™™™™™ @333333"@333333!@$@333333$@ÍÌÌÌÌÌ"@333333#@ÍÌÌÌÌÌ"@ÍÌÌÌÌÌ@š™™™™™#@"@%@ø333333%@#@333333"@333333"@š™™™™™#@333333@ffffff#@š™™™™™ @ÍÌÌÌÌÌ"@)@)@ÍÌÌÌÌÌ"@ffffff @š™™™™™@333333$@ffffff"@ffffff&@ffffff@ÍÌÌÌÌÌ(@ffffff+@%@ffffff#@š™™™™™@$@#@'@ffffff$@"@š™™™™™@"@ @@š™™™™™@š™™™™™ @#@ffffff!@333333 @ffffff$@ffffff"@333333!@333333 @(@ÍÌÌÌÌÌ!@#@š™™™™™$@ffffff!@ÍÌÌÌÌÌ$@333333"@ffffff"@*@333333!@333333"@ffffff!@ÍÌÌÌÌÌ@@"@ffffff @ÍÌÌÌÌÌ@333333!@333333!@ffffff@š™™™™™'@ffffff%@333333"@ffffff%@$@ÍÌÌÌÌÌ@$@ÍÌÌÌÌÌ&@%@š™™™™™@ÍÌÌÌÌÌ@š™™™™™$@ffffff@'@ffffff"@ffffff$@333333*@š™™™™™!@ÍÌÌÌÌÌ"@ffffff#@$@ @333333@ffffff&@š™™™™™'@333333 @&@ ?@4 4ÿ‚èå'ÕL€TREEÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿ(â pŒÐð”€øé0'ÕL€SNODápã €äØ3ð'ÕL€(ë0'ÕL€øøøð?ð?ð?ð?øøð?@ð?ð?ð?øøð?@ð?ð?øð?@ð?ð?øð?ð?ð?ø@øø@@@ð?ð?ð?@øøð?øø@ð?ð?ð?ð?ð?@ð?ø@øøð?@øð?øð?@ð?ð?@@@@@øð?@@øøð?@@@ø@øøøð?øð?øð?øøð?@@@@øð?@ð?ð?ð?ð?ð?ð?@ð?ð?ø@øøøø@ð?ð?@ð?ð?øð?@øð?ð?ø@ ÈÅO ÈÅN ÈÅMÈÅKÈÅLÈÅFÈÅGÈÅHÈÅIÈÅJ ÈÅ=ÈÅ>ÈÅ? ÈÅ@ÈÅAÈÅBÈÅCÈÅD"ÈÅEÈÅqÈÅp ÈÅo ÈÅmÈÅnÈÅhÈÅiÈÅjÈÅkÈÅl ÈÅ_ ÈÅ` ÈÅaÈÅbÈÅc ÈÅd ÈÅeÈÅf ÈÅg